Sinha Vikas
SEC CIK 1337845 · EDGAR
BoughtSold
Most active insiders at SRRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AKKARAJU SRINIVAS | Dir | $19.99M | — |
| 2 | Qatanani Mo | CSO | — | $8.60M |
| 3 | Hallal David | CEO, Dir | — | $3.97M |
| 4 | Vaishnaw Akshay | Pres of R, D, Dir | — | $1.48M |
| 5 | Sinha Vikas | CFO | — | $1.23M |
| 6 | Woods Keith | COO | — | $1.22M |
| 7 | Ho Junlin | GC | — | $802.3K |
| 8 | Parlavecchio Caryn | CHRO | — | $714.0K |
| 9 | Marantz Jing L. | Chief Medical Off | — | $451.3K |
| 10 | Peng Katie | Dir | — | $337.8K |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-20 18:09 | 2026-04-16 | SRRK | Scholar Rock Holding Corp | Sinha Vikas | CFO | S - Sale | $49.57 | -10.4K | 619.9K | -2% | -$516.1K | |
| 2026-02-11 | 2026-02-09 | SRRK | Scholar Rock Holding Corp | Sinha Vikas | CFO | A - Grant | $0.00 | +47.0K | 630.3K | +8% | $0 | |
| 2026-01-15 | 2026-01-13 | SRRK | Scholar Rock Holding Corp | Sinha Vikas | CFO | S - Sale | $42.70 | -16.8K | 583.2K | -3% | -$715.4K | |
| M | 2025-04-29 | 2025-04-27 | SRRK | Scholar Rock Holding Corp | Sinha Vikas | CFO | A - Grant | $0.00 | +600.0K | 600.0K | New | $0 |
| 2025-02-24 | 2025-02-21 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $10.08 | -303 | 49.1K | -0.6% | -$3,054 | |
| M | 2025-01-27 | 2025-01-23 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $9.50 | -129 | 49.4K | -0.3% | -$1,225 |
| 2025-01-13 | 2025-01-10 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.44 | -979 | 1.14M | -0.1% | -$430.76 | |
| 2024-11-20 | 2024-11-19 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.55 | -3,186 | 1.14M | -0.3% | -$1,752 | |
| 2024-11-06 | 2024-11-05 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.86 | -5,136 | 1.14M | -0.4% | -$4,417 | |
| M | 2024-10-23 | 2024-10-21+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.7745 | -3,428 | 1.15M | -0.3% | -$2,655 |
| 2024-10-04 | 2024-10-03 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.81 | -940 | 1.15M | -0.1% | -$761.40 | |
| 2024-08-20 | 2024-08-19 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.76 | -3,159 | 1.15M | -0.3% | -$2,401 | |
| 2024-08-07 | 2024-08-05 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.73 | -5,251 | 1.16M | -0.5% | -$3,833 | |
| M | 2024-07-23 | 2024-07-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.7445 | -3,400 | 1.16M | -0.3% | -$2,531 |
| 2024-07-03 | 2024-07-02 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.72 | -939 | 1.17M | -0.1% | -$676.08 | |
| 2024-05-21 | 2024-05-17 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.75 | -3,143 | 1.13M | -0.3% | -$2,357 | |
| 2024-05-07 | 2024-05-03 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.8 | -4,957 | 1.13M | -0.4% | -$3,966 | |
| M | 2024-04-23 | 2024-04-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.75 | -3,378 | 1.14M | -0.3% | -$2,534 |
| 2024-04-04 | 2024-04-02 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.77 | -885 | 1.14M | -0.1% | -$681.45 | |
| 2024-02-22 | 2024-02-20 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.7 | -2,893 | 1.14M | -0.3% | -$2,025 | |
| 2024-02-06 | 2024-02-05 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.67 | -18.3K | 1.15M | -2% | -$12.3K | |
| 2024-01-25 | 2024-01-23 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.67 | -3,205 | 1.16M | -0.3% | -$2,147 | |
| 2024-01-08 | 2024-01-04 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $0.64 | -961 | 1.17M | -0.1% | -$615.04 | |
| 2023-11-21 | 2023-11-17 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $1.63 | -2,490 | 1.17M | -0.2% | -$4,059 | |
| M | 2023-10-23 | 2023-10-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $1.56 | -2,707 | 1.17M | -0.2% | -$4,218 |
| 2023-10-05 | 2023-10-03 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $1.98 | -755 | 1.17M | -0.1% | -$1,495 | |
| 2023-08-21 | 2023-08-17 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $2.50 | -10.5K | 1.17M | -0.9% | -$26.3K | |
| M | 2023-07-21 | 2023-07-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.45 | -2,635 | 1.19M | -0.2% | -$9,079 |
| 2023-07-06 | 2023-07-05 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.05 | -2,983 | 1.19M | -0.3% | -$9,098 | |
| M | 2023-04-21 | 2023-04-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.67 | -2,683 | 1.19M | -0.2% | -$9,837 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | A - Grant | $0.00 | +157.5K | 1.19M | +15% | $0 |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $5.09 | -6,537 | 1.03M | -0.6% | -$33.3K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $9.36 | -1,449 | 1.04M | -0.1% | -$13.6K |
| 2022-10-24 | 2022-10-19 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $9.36 | -1,449 | 1.04M | -0.1% | -$13.6K | |
| 2022-08-17 | 2022-08-16 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +100.0K | 1.04M | +11% | $0 | |
| I | 2022-08-01 | 2022-07-28 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M |
| 2022-07-21 | 2022-07-20 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | S - Sale | $5.21 | -1,432 | 938.2K | -0.2% | -$7,461 | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +29.4K | 939.7K | +3% | $0 |
| 2022-04-22 | 2022-04-20 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | S - Sale | $6.68 | -1,162 | 906.6K | -0.1% | -$7,762 | |
| D | 2022-04-04 | 2022-01-18 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +48.8K | 907.8K | +6% | $0 |
| 2022-01-24 | 2022-01-20 | KLRS | Kalaris Therapeutics, Inc. | Sinha Vikas | See Remarks, Dir | S - Sale | $8.75 | -6,450 | 859.0K | -0.7% | -$56.4K |
Purchase Sale Sale after option exercise All abbreviations